Soria, Spain

Raquel Munoz Martinez


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Raquel Munoz Martinez: Innovator in Non-Toxic Ribosome Inactivating Proteins

Introduction

Raquel Munoz Martinez is a prominent inventor based in Soria, Spain. She has made significant contributions to the field of biochemistry, particularly in the development of non-toxic ribosome inactivating proteins (RIPs). Her innovative work has the potential to impact various applications in cellular biology and medicine.

Latest Patents

Raquel holds a patent for her invention titled "Non-toxic ribosome inactivating proteins (RIPs) with two chains." This invention discloses ribosome inactivating proteins that are not toxic in the extracellular environment and are of plant origin. These proteins can interact with ribonucleic acid, inhibiting protein biosynthesis in cellular systems. The proteins consist of two chains, A and B, where chain A exhibits N-glucosidase activity on ribosomal RNA, and chain B has lectin activity, both connected by disulfide bridges. Among the notable proteins mentioned in her patent are Nigrine b, basic Nigrine l, Ebuline 1, and Racenosine b, all isolated from various species of the Sambucus plant.

Career Highlights

Raquel is affiliated with the Universidad de Valladolid, where she continues her research and development in the field of biochemistry. Her work has garnered attention for its innovative approach to creating non-toxic proteins that can be utilized in various scientific applications.

Collaborations

Raquel has collaborated with esteemed colleagues, including Tomas Girbes Juan and Jose Miguel Ferreras Rodriguez. Their combined expertise has contributed to the advancement of research in ribosome inactivating proteins.

Conclusion

Raquel Munoz Martinez is a trailblazer in the field of biochemistry, with her innovative patent on non-toxic ribosome inactivating proteins showcasing her commitment to advancing scientific knowledge. Her contributions have the potential to lead to significant advancements in cellular biology and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…